单位(元)南方医药创新股票C(010593)资产负债表 |
报告期 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
2022/6/30 |
资产 |
银行存款 |
28,142,828 |
84,489,116 |
174,992,492 |
165,737,602 |
结算备付金 |
2,393,788 |
10,150,589 |
5,484,510 |
619,793 |
存出保证金 |
409,128 |
1,049,031 |
599,389 |
653,293 |
交易性金融资产 |
1,859,763,445 |
2,026,600,126 |
2,119,060,682 |
2,179,024,807 |
其中:股票投资 |
1,768,218,717 |
1,922,290,585 |
2,027,394,750 |
2,064,639,061 |
基金投资 |
- |
- |
- |
- |
债券投资 |
91,544,728 |
104,309,541 |
91,665,932 |
114,385,746 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
59,990,834 |
- |
- |
- |
应收证券清算款 |
13,469,539 |
23,480,971 |
- |
- |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
23,856 |
- |
95,553 |
应收申购款 |
992,231 |
589,958 |
1,154,874 |
4,032,486 |
其他资产 |
- |
- |
- |
- |
资产总计 |
1,965,161,792 |
2,146,383,646 |
2,301,291,947 |
2,350,163,535 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
8,612,939 |
44,972,673 |
22,734,240 |
28,026,885 |
应付赎回款 |
1,794,851 |
2,328,404 |
7,491,373 |
6,560,118 |
应付管理人报酬 |
2,012,331 |
2,642,831 |
2,823,128 |
2,670,350 |
应付托管费 |
335,389 |
440,472 |
470,521 |
445,058 |
应付销售服务费 |
342,649 |
361,668 |
400,217 |
373,631 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
16 |
- |
15 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
1,517,330 |
4,632,224 |
3,816,378 |
678,274 |
负债合计 |
14,615,489 |
55,378,288 |
37,735,857 |
38,754,331 |
所有者权益 |
实收基金 |
3,593,866,492 |
3,705,384,047 |
3,816,306,519 |
3,761,179,160 |
未分配利润 |
-1,643,320,189 |
-1,614,378,688 |
-1,552,750,429 |
-1,449,769,956 |
所有者权益合计 |
1,950,546,303 |
2,091,005,358 |
2,263,556,090 |
2,311,409,204 |
负债和所有者权益总计 |
1,965,161,792 |
2,146,383,646 |
2,301,291,947 |
2,350,163,535 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。